Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines

Key Points

• To explore the use of silica-coated papillomavirus-based nanoparticles for HIV-1 vaccine delivery.
• Utilized silica-coated nanoparticles for the formulation of an HIV-1 vaccine.
• Assessed safety and efficacy of the nanoparticle platform.
• Conducted immunological analyses to evaluate vaccine response.
• Demonstrated enhanced delivery of HIV-1 antigens using nanoparticle technology.
• Indicated improved immune responses in preclinical models with silica-coated papillomavirus.
• Showed potential for developing a more effective HIV-1 vaccine.